Pharmaceutical giant Bayer announced Thursday it had agreed to pay $1.6 billion to settle nearly all claims filed in the United States over controversial birth control implant Essure.
Aug 20, 2020
0
0
When cancer patients take part in a clinical trial to develop new therapies, they and their physicians want to know how they will feel and function during treatment. A new collaboration between Bayer and The University of ...
Jan 23, 2015
0
13
In a win for consumers, the California Supreme Court ruled Thursday that settlement agreements between pharmaceutical companies that keep cheaper, generic drugs off the market may be illegal if they include excessive cash ...
May 7, 2015
0
10
German chemicals giant Bayer said on Thursday it was selling its male testosterone replacement drug Nebido for up to half-a-billion euros in order to concentrate on medical innovation.
Jul 14, 2022
0
3
A federal appeals court has ruled that the EPA must take another look at whether the key ingredient in the weed killer Roundup poses a cancer risk, although the product will remain on the market for now.
Jun 20, 2022
0
3
German pharmaceutical firms Bayer and CureVac said Thursday that they have joined forces in the development and supply of CureVac's COVID-19 vaccine candidate.
Jan 7, 2021
0
2
Drugmaker Merck said Wednesday that it completed the sale of its consumer care business, which makes products including Claritin allergy medication and Coppertone sun-care line, to German health care company Bayer for $14.2 ...
Oct 1, 2014
0
0
German health care company Bayer said Monday it is buying Asklepios BioPharmaceutical, a U.S.-based firm specializing in gene therapy, in a deal worth up to $4 billion.
Oct 26, 2020
0
1
The United States government accused Bayer of making scientifically unproven statements about the health benefits of a popular probiotic on Friday, claiming the German pharmaceutical giant was in contempt of court.
Sep 12, 2014
1
0
German pharmaceuticals giant Bayer, maker of Aspirin, on Wednesday named Werner Baumann as its new chief executive to replace Marijn Dekkers, who is stepping down at the end of April.
Feb 24, 2016
0
0
